Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2013 | 03-2013 | 12-2012 | |
| Operating Expenses | 3 | 9 | 1 |
| Operating Income | -3 | -9 | -1 |
| Interest Expense | 1 | 1 | 1 |
| Pre-tax Income | -4 | -10 | -1 |
| Net Income Continuous | -4 | -10 | -1 |
| Net Income | $-4 | $-10 | $-1 |
| EPS Basic Total Ops | -0.09 | -0.21 | -0.03 |
| EPS Basic Continuous Ops | -0.09 | -0.21 | -0.03 |
| EPS Diluted Total Ops | -0.09 | -0.21 | -0.03 |
| EPS Diluted Continuous Ops | -0.09 | -0.21 | -0.03 |
| EBITDA(a) | $-3 | $-9 | $-1 |